Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a Ki of 0
InChiKey: YBGGBHCJSAEIAS-UHFFFAOYSA-N
and impair triglyceride and/or phospholipid biosynthesis
Chemical Name: 4-{ethyl[1-(4-methoxyphenyl)propan-2-yl]amino}butan-1-ol
1239908-20-3
Palbociclib 1150 compound 5) is a potentPalbociclib, also known as PD 0332991, is an orally available cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine threonine kinases that
US$ 22.00
US$ 38.00
US$ 54.95
US$ 40.00
US$ 193.00
US$ 25.95
US$ 44.95
US$ 14.00